Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Prowess of Bionano Genomics' Saphyr System in Uncovering Novel Genetic Variations That Cause Cancer and Genetic Disease in Full Display at ASHG 2020

GlobeNewswire October 27, 2020

Rockefeller University Scientist Uses Bionano Saphyr to Analyze Genomes of Patients and Animals Susceptible to COVID-19

GlobeNewswire October 26, 2020

Bionano Genomics Releases Major Update to Its Suite of Software Tools That Simplifies Clinical Analysis, Reduces Time to Actionable Results and Makes Adoption by Clinical Labs Easier

GlobeNewswire October 21, 2020

Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing Variants

GlobeNewswire October 15, 2020

Bionano Genomics to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 12

GlobeNewswire October 15, 2020

Bionano's Saphyr Plays Essential Role in Identifying Three Previously Unknown Genetic Mutation Types in Cancer in Study from Weill Cornell

GlobeNewswire October 8, 2020

Boston Children's Hospital Is Using Bionano's Saphyr To Study Children With Severe COVID-19 Disease

GlobeNewswire October 5, 2020

Bionano Genomics Announces Positive Outcome of Its Special Stockholder Meeting

GlobeNewswire September 30, 2020

Bionano Genomics Announces Continued Expansion of Global Business with Adoption of Saphyr for Next-Generation Cytogenomics in Eastern Europe and Australia

GlobeNewswire September 29, 2020

German Accreditation of Laboratory Developed Tests on Bionano's Saphyr System Accelerates Utilization in Clinical Diagnostics

GlobeNewswire September 24, 2020

Bionano to Present at the September 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

GlobeNewswire September 21, 2020

Bionano Data Provides Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALS

GlobeNewswire September 17, 2020

Bionano Genomics Continues to See Expansion in the Adoption of Saphyr for Digital Cytogenetics at Leading Medical Institutions

GlobeNewswire September 16, 2020

Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen's EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy

GlobeNewswire September 14, 2020

Bionano Genomics Announces Continued Expansion of European Business With Adoption of Saphyr at Three of Europe's Largest Pediatric Hospitals in Spain, Italy and France

GlobeNewswire September 10, 2020

Vertebrate Genome Project Rules Bionano Optical Mapping Technology As Essential Part of Assembling Reference Quality Genomes

GlobeNewswire September 9, 2020

Bionano Genomics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 4, 2020

Independent Proxy Advisory Firm ISS Recommends Bionano Stockholders Vote "FOR" Authorized Shares Increase Proposal

GlobeNewswire September 3, 2020

Bionano Genomics Data is a Key to Understanding Cancer Genome Structures That Make Tumors Grow Aggressively

GlobeNewswire September 2, 2020

Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020

GlobeNewswire August 31, 2020